𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anorectal temperature sensation: A comparison of normal and incontinent patients

✍ Scribed by J. Rogers

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
140 KB
Volume
74
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anorectal sampling: A comparison of norm
Anorectal sampling: A comparison of normal and incontinent patients
✍ R. Miller Mr; D. C. C. Bartolo; F. Cervero; N. J. McC. Mortensen πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 536 KB

Abstract It has been suggested that sampling of rectal contents by the anal canal may play a role in the continence mechanism. To investigate this concept we studied 18 patients with faecal incontinence and 18 age and sex matched controls. A microtransducer catheter was positioned so that pressures

Comparison of sensation-related voiding
Comparison of sensation-related voiding patterns between continent and incontinent women: A study with a 3-day sensation-related bladder diary (SR-BD)
✍ Irina Naoemova; Stefan De Wachter; Jean-Jacques Wyndaele πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Abstract ## Aim To describe and compare voiding patterns on a 3‐day sensation‐related bladder diary (SR‐BD) in women with urinary incontinence (UI) and healthy volunteers. ## Methods A total of 251 women (224 incontinent patients and 27 healthy volunteers) who recorded a 3‐day SR‐BD and under

Comparison of a 10-mg controlled release
Comparison of a 10-mg controlled release oxybutynin tablet with a 5-mg oxybutynin tablet in urge incontinent patients
✍ Carl Gustaf Nilsson; Eeva Lukkari; Mervi Haarala; Aarre KivelΓ€; Tiina Hakonen; P πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 68 KB

Oxybutynin has long been used for the treatment of patients with detrusor overactivity and urinary urge incontinence. The short half-life of oxybutynin administered as a conventional tablet formulation or syrup requires 2-3 times daily dosage to be effective. A new controlled release (CR) tablet for